Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 775

1.

Anti-gluten IgE titer is associated with severity of provocation test-evoked symptoms in wheat-dependent exercise-induced anaphylaxis.

Sugiyama A, Kishikawa R, Honjo S, Nishie H, Iwanaga T, Furue M.

Allergol Int. 2019 Jun 5. pii: S1323-8930(19)30057-7. doi: 10.1016/j.alit.2019.04.007. [Epub ahead of print] No abstract available.

2.

Histopathologic features of melanocytic tumors in Xiphophorus melanoma receptor kinase (xmrk)-transgenic medaka (Oryzias latipes).

Sugiyama A, Schartl M, Naruse K.

J Toxicol Pathol. 2019 Apr;32(2):111-117. doi: 10.1293/tox.2018-0058. Epub 2019 Feb 1.

3.

[Neuropsychiatric Systemic Lupus Erythematosus: From the Standpoint of Department of Neurology].

Sugiyama A, Kuwabara S.

Brain Nerve. 2019 May;71(5):459-471. doi: 10.11477/mf.1416201298. Japanese.

PMID:
31088995
4.

Exploring the frequency and clinical background of the "zebra sign" in amyotrophic lateral sclerosis and multiple system atrophy.

Sugiyama A, Sato N, Kimura Y, Shigemoto Y, Suzuki F, Morimoto E, Takahashi Y, Matsuda H, Kuwabara S.

J Neurol Sci. 2019 Jun 15;401:90-94. doi: 10.1016/j.jns.2019.04.032. Epub 2019 Apr 24.

PMID:
31075684
5.

TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.

Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, Eto M, Yao M, Kamba T, Suda T, Oike Y, Schmidt LS, Linehan WM.

Mol Cancer Res. 2019 May 1. doi: 10.1158/1541-7786.MCR-18-1235. [Epub ahead of print]

PMID:
31043488
6.

Uptake of adenine by purine permeases of Coffea canephora.

Kakegawa H, Shitan N, Kusano H, Ogita S, Yazaki K, Sugiyama A.

Biosci Biotechnol Biochem. 2019 Jul;83(7):1300-1305. doi: 10.1080/09168451.2019.1606698. Epub 2019 Apr 18.

PMID:
30999827
7.

The severity of motor dysfunctions and urinary dysfunction is not correlated in multiple system atrophy.

Yamamoto T, Yamanaka Y, Sugiyama A, Hirano S, Uchiyama T, Asahina M, Sakakibara R, Kuwabara S.

J Neurol Sci. 2019 May 15;400:25-29. doi: 10.1016/j.jns.2019.03.005. Epub 2019 Mar 12.

PMID:
30884369
8.

Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.

Asari Y, Kageyama K, Sugiyama A, Kogawa H, Niioka K, Daimon M.

Endocr J. 2019 Mar 15. doi: 10.1507/endocrj.EJ18-0491. [Epub ahead of print]

9.

B-ring-homo-tonghaosu, isolated from Chrysanthemum morifolium capitulum, acts as a peroxisome proliferator-activated receptor-γ agonist.

Zhang F, Ishiuchi K, Sugiyama A, Ohsawa M, Makino T.

J Nat Med. 2019 Jun;73(3):497-503. doi: 10.1007/s11418-019-01290-y. Epub 2019 Feb 21.

PMID:
30790129
10.

Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth.

Oshima T, Niwa Y, Kuwata K, Srivastava A, Hyoda T, Tsuchiya Y, Kumagai M, Tsuyuguchi M, Tamaru T, Sugiyama A, Ono N, Zolboot N, Aikawa Y, Oishi S, Nonami A, Arai F, Hagihara S, Yamaguchi J, Tama F, Kunisaki Y, Yagita K, Ikeda M, Kinoshita T, Kay SA, Itami K, Hirota T.

Sci Adv. 2019 Jan 23;5(1):eaau9060. doi: 10.1126/sciadv.aau9060. eCollection 2019 Jan.

11.

Morphology and physiology of rat placenta for toxicological evaluation.

Furukawa S, Tsuji N, Sugiyama A.

J Toxicol Pathol. 2019 Jan;32(1):1-17. doi: 10.1293/tox.2018-0042. Epub 2018 Oct 15. Review.

12.

Electropharmacological effects of intracellular Ca2+ handling modulator caldaret on the heart assessed in the halothane-anesthetized dogs.

Sugiyama A, Hagiwara-Nagasawa M, Kambayashi R, Goto A, Chiba K, Ando K, Naito AT, Izumi-Nakaseko H.

J Pharmacol Sci. 2019 Mar;139(3):180-185. doi: 10.1016/j.jphs.2019.01.004. Epub 2019 Jan 24.

13.

Characterization of microminipig as a laboratory animal for safety pharmacology study by analyzing fluvoxamine-induced cardiovascular and dermatological adverse reactions.

Tanikawa Y, Hagiwara-Nagasawa M, Kambayashi R, Goto A, Chiba K, Kitta K, Hoshiai K, Izumi-Nakaseko H, Naito AT, Sugiyama A.

Cardiovasc Toxicol. 2019 Feb 8. doi: 10.1007/s12012-019-09509-w. [Epub ahead of print]

PMID:
30734885
14.

Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats.

Sugiyama A, Mitsui A, Okada M, Yamawaki H.

J Vet Med Sci. 2019 Apr 16;81(4):522-531. doi: 10.1292/jvms.18-0674. Epub 2019 Feb 7.

15.

Measurement of J-Tpeakc along with QT-Interval Prolongation May Increase the Assay Sensitivity and Specificity for Predicting the Onset of Drug-Induced Torsade de Pointes: Experimental Evidences Based on Proarrhythmia Model Animals.

Goto A, Hagiwara-Nagasawa M, Kambayashi R, Chiba K, Izumi-Nakaseko H, Naito AT, Kanda Y, Sugiyama A.

Cardiovasc Toxicol. 2019 Feb 2. doi: 10.1007/s12012-019-09506-z. [Epub ahead of print]

PMID:
30712162
16.

[Benefit of Adjuvant Chemotherapy after Curative Resection of Liver and Lung Metastases in Colorectal Cancer].

Muramatsu S, Chika N, Amano K, Hatano S, Ishiguro T, Kumagai Y, Ishibashi K, Mochiki E, Ishida H, Sugiyama A, Inoue Y, Aoki K, Fukuda H, Gika M, Nakayama M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2189-2192. Japanese.

PMID:
30692327
17.

Systemic administration of a delta opioid receptor agonist, KNT-127, facilitates extinction learning of fear memory in rats.

Sugiyama A, Yamada M, Furuie H, Gotoh L, Saitoh A, Nagase H, Oka JI, Yamada M.

J Pharmacol Sci. 2019 Mar;139(3):174-179. doi: 10.1016/j.jphs.2019.01.002. Epub 2019 Jan 17.

18.

Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease.

Zuoyou L, Shiota S, Morio Y, Sugiyama A, Sekiya M, Iwakami SI, Ienaga H, Fukuchi Y, Takahashi K.

Respir Physiol Neurobiol. 2019 Apr;262:20-25. doi: 10.1016/j.resp.2019.01.003. Epub 2019 Jan 17.

PMID:
30660859
19.

The Crotalaria juncea metal transporter CjNRAMP1 has a high Fe uptake activity, even in an environment with high Cd contamination.

Nakanishi-Masuno T, Shitan N, Sugiyama A, Takanashi K, Inaba S, Kaneko S, Yazaki K.

Int J Phytoremediation. 2018;20(14):1427-1437. doi: 10.1080/15226514.2018.1501333. Epub 2019 Jan 17.

PMID:
30652514
20.

Hepatology Highlights.

Russo N, Jesudian A, Shen NT, Brown RS Jr, Sugiyama A, Nicholls HT, Pisa JF, Krisko TI, Rosenblatt R, Tafesh ZH, Fortune BE, Mousa O, Malhi H, Schwartz RE, Gupta V, Kulai TB, Malhi H.

Hepatology. 2019 Jan;69(1):1-4. doi: 10.1002/hep.30480. No abstract available.

PMID:
30618107
21.

Each liver X receptor (LXR) type has a different purpose in different situations.

Yonezawa S, Abe M, Kawasaki Y, Natori Y, Sugiyama A.

Biochem Biophys Res Commun. 2019 Jan 1;508(1):92-96. doi: 10.1016/j.bbrc.2018.11.076. Epub 2018 Nov 22.

PMID:
30471864
22.

Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.

Nagashima S, Yamamoto C, Ko K, Chuon C, Sugiyama A, Ohisa M, Akita T, Katayama K, Yoshihara M, Tanaka J.

Vaccine. 2019 Jan 3;37(1):145-151. doi: 10.1016/j.vaccine.2018.11.019. Epub 2018 Nov 16.

23.

Use of microminipigs for unveiling unknown mechanisms of azithromycin-induced cardiovascular death.

Goto A, Hagiwara-Nagasawa M, Izumi-Nakaseko H, Kitta K, Hoshiai K, Chiba K, Ando K, Akie Y, Naito AT, Sugiyama A.

J Pharmacol Sci. 2018 Nov;138(3):198-202. doi: 10.1016/j.jphs.2018.10.003. Epub 2018 Oct 17.

24.

Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study.

Uchida S, Satake M, Kurisu A, Sugiyama A, Ko K, Akita T, Tanaka J.

Transfusion. 2018 Dec;58(12):2880-2885. doi: 10.1111/trf.14951. Epub 2018 Oct 30.

PMID:
30376600
25.

Resolving the paradox of clumped seed dispersal: positive density and distance dependence in a bat-dispersed species.

Sugiyama A, Comita LS, Masaki T, Condit R, Hubbell SP.

Ecology. 2018 Nov;99(11):2583-2591. doi: 10.1002/ecy.2512. Epub 2018 Oct 15.

PMID:
30182375
26.

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel.

Seino M, Ohta T, Sugiyama A, Sakaki H, Sudo T, Tsutsumi S, Shigeta S, Tokunaga H, Toyoshima M, Yaegashi N, Nagase S.

Oncotarget. 2018 Aug 10;9(62):31985-31998. doi: 10.18632/oncotarget.25868. eCollection 2018 Aug 10.

27.

Comparative Proteomic Analysis of Lithospermum erythrorhizon Reveals Regulation of a Variety of Metabolic Enzymes Leading to Comprehensive Understanding of the Shikonin Biosynthetic Pathway.

Takanashi K, Nakagawa Y, Aburaya S, Kaminade K, Aoki W, Saida-Munakata Y, Sugiyama A, Ueda M, Yazaki K.

Plant Cell Physiol. 2019 Jan 1;60(1):19-28. doi: 10.1093/pcp/pcy183.

PMID:
30169873
28.

Diagnostic Challenges Posed by Preceding Peripheral Neuropathy in Very Late-onset Spinocerebellar Ataxia Type 3.

Sugiyama A, Sekiguchi Y, Beppu M, Ishige T, Matsushita K, Kuwabara S.

Intern Med. 2019 Jan 1;58(1):119-122. doi: 10.2169/internalmedicine.1382-18. Epub 2018 Aug 24.

29.

Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.

Izumi-Nakaseko H, Hagiwara-Nagasawa M, Naito AT, Goto A, Chiba K, Sekino Y, Kanda Y, Sugiyama A.

J Pharmacol Sci. 2018 Aug;137(4):372-378. doi: 10.1016/j.jphs.2018.07.011. Epub 2018 Aug 4.

30.

MITE insertion-dependent expression of CitRKD1 with a RWP-RK domain regulates somatic embryogenesis in citrus nucellar tissues.

Shimada T, Endo T, Fujii H, Nakano M, Sugiyama A, Daido G, Ohta S, Yoshioka T, Omura M.

BMC Plant Biol. 2018 Aug 13;18(1):166. doi: 10.1186/s12870-018-1369-3.

31.

Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines with Human β4-Galactosyltransferase 4 Gene Promoters.

Fukushima N, Sugiyama A, Sato T.

Sensors (Basel). 2018 Aug 6;18(8). pii: E2573. doi: 10.3390/s18082573.

32.

Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir.

Lubna NJ, Nakamura Y, Hagiwara-Nagasawa M, Goto A, Chiba K, Kitta K, Izumi-Nakaseko H, Ando K, Naito AT, Akie Y, Sugiyama A.

J Toxicol Sci. 2018;43(8):507-512. doi: 10.2131/jts.43.507.

33.

Reply.

Sugiyama A, Sato N.

AJNR Am J Neuroradiol. 2018 Sep;39(9):E102. doi: 10.3174/ajnr.A5757. Epub 2018 Aug 2. No abstract available.

PMID:
30072370
34.

Knocking the Chest as a "Bridge to Pacemaker": Treatment of Bradyasystole by Percussion Pacing - Reply.

Wada T, Hagiwara-Nagasawa M, Yoshihara K, Nakazato Y, Lurie KG, Sugiyama A.

Circ J. 2018 Aug 24;82(9):2446-2447. doi: 10.1253/circj.CJ-18-0765. Epub 2018 Aug 1. No abstract available.

35.

Administration of a delta opioid receptor agonist KNT-127 to the basolateral amygdala has robust anxiolytic-like effects in rats.

Sugiyama A, Yamada M, Saitoh A, Nagase H, Oka JI, Yamada M.

Psychopharmacology (Berl). 2018 Oct;235(10):2947-2955. doi: 10.1007/s00213-018-4984-7. Epub 2018 Jul 31.

PMID:
30066134
36.

Metastatic thymic tumor arising from spermatic cord leiomyosarcoma.

Aoki K, Yamaguchi M, Sugiyama A, Inoue Y, Fukuda H, Gika M, Yamazaki M, Kawano R, Momose S, Nakayama M.

Gen Thorac Cardiovasc Surg. 2019 May;67(5):490-492. doi: 10.1007/s11748-018-0973-3. Epub 2018 Jul 21.

PMID:
30032446
37.

Natural course of persistent hepatitis B virus infection in hepatitis B e antigen-positive and hepatitis B e antigen-negative cohorts in Japan based on the Markov model.

Yamasaki K, Tanaka J, Kurisu A, Akita T, Ohisa M, Sakamune K, Ko K, Sugiyama A, Yasaka T, Shirahama S.

J Med Virol. 2018 Dec;90(12):1800-1813. doi: 10.1002/jmv.25260. Epub 2018 Sep 3.

PMID:
29995323
38.

Teaching NeuroImages: Cerebral cortex swelling in Creutzfeldt-Jakob disease with V180I mutation.

Sugiyama A, Beppu M, Kuwabara S.

Neurology. 2018 Jul 10;91(2):e185-e186. doi: 10.1212/WNL.0000000000005779. No abstract available.

PMID:
29987185
39.

Analysis of torsadogenic and pharmacokinetic profile of E-4031 in dogs bridging the gap of information between in vitro proarrhythmia assay and clinical observation in human subjects.

Goto A, Izumi-Nakaseko H, Hagiwara-Nagasawa M, Chiba K, Ando K, Naito AT, Sugiyama A.

J Pharmacol Sci. 2018 Jun;137(2):237-240. doi: 10.1016/j.jphs.2018.06.005. Epub 2018 Jun 18.

40.

Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.

Kageyama K, Sakihara S, Kameda W, Sugiyama A, Takayasu S, Terui K, Daimon M.

Endocr J. 2018 Oct 29;65(10):1049-1054. doi: 10.1507/endocrj.EJ17-0527. Epub 2018 Jul 5.

41.

Analysis of Safety Margin of Lithium Carbonate Against Cardiovascular Adverse Events Assessed in the Halothane-Anesthetized Dogs.

Goto A, Nakamura Y, Lubna NJ, Chiba K, Hagiwara-Nagasawa M, Izumi-Nakaseko H, Ando K, Naito AT, Sugiyama A.

Cardiovasc Toxicol. 2018 Dec;18(6):530-536. doi: 10.1007/s12012-018-9464-0.

PMID:
29845450
42.

Sunitinib does not acutely alter left ventricular systolic function, but induces diastolic dysfunction.

Wada T, Ando K, Naito AT, Nakamura Y, Goto A, Chiba K, Lubna NJ, Cao X, Hagiwara-Nagasawa M, Izumi-Nakaseko H, Nakazato Y, Sugiyama A.

Cancer Chemother Pharmacol. 2018 Jul;82(1):65-75. doi: 10.1007/s00280-018-3593-9. Epub 2018 May 2.

PMID:
29721849
43.

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N.

Nat Commun. 2018 Apr 27;9(1):1685. doi: 10.1038/s41467-018-03966-7.

44.

High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies.

Lingani M, Akita T, Ouoba S, Sanou AM, Sugiyama A, Tarnagda Z, Ohisa M, Tinto H, Mishiro S, Tanaka J.

BMC Public Health. 2018 Apr 25;18(1):551. doi: 10.1186/s12889-018-5432-7.

45.

Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.

Kandori S, Kojima T, Matsuoka T, Yoshino T, Sugiyama A, Nakamura E, Shimazui T, Funakoshi Y, Kanaho Y, Nishiyama H.

Cancer Sci. 2018 Jun;109(6):1865-1875. doi: 10.1111/cas.13609. Epub 2018 May 25.

46.

Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy Filipino subjects: Exposure-response modeling using ECG data of thorough QT/QTc study.

Matsukura S, Nakamura Y, Hoshiai K, Hayashi T, Koga T, Goto A, Chiba K, Lubna NJ, Hagiwara-Nagasawa M, Izumi-Nakaseko H, Ando K, Naito AT, Sugiyama A.

J Pharmacol Sci. 2018 Apr;136(4):234-241. doi: 10.1016/j.jphs.2018.01.009. Epub 2018 Mar 27.

47.

Perforation of a Peptic Ulcer in a Hiatal Hernia Into the Left Ventricle With Systemic Air and Food Embolism.

Igarashi I, Suzuki K, Hosono F, Ichinose A, Abe S, Sugiyama A, Sekido Y.

J Comput Assist Tomogr. 2018 Sep/Oct;42(5):767-770. doi: 10.1097/RCT.0000000000000747.

PMID:
29613995
48.

Reduction of Membrane Protein CRIM1 Decreases E-Cadherin and Increases Claudin-1 and MMPs, Enhancing the Migration and Invasion of Renal Carcinoma Cells.

Ogasawara N, Kudo T, Sato M, Kawasaki Y, Yonezawa S, Takahashi S, Miyagi Y, Natori Y, Sugiyama A.

Biol Pharm Bull. 2018;41(4):604-611. doi: 10.1248/bpb.b17-00990.

49.

High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification.

Sugiyama A, Umetsu M, Nakazawa H, Niide T, Asano R, Hattori T, Kumagai I.

J Biosci Bioeng. 2018 Aug;126(2):153-161. doi: 10.1016/j.jbiosc.2018.02.007. Epub 2018 Mar 13.

PMID:
29548844
50.

Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine.

Ando K, Nakamura Y, Hagiwara-Nagasawa M, Harada H, Miyamoto H, Inamura N, Takagi K, Goto A, Chiba K, Lubna NJ, Izumi-Nakaseko H, Naito AT, Sugiyama A.

J Toxicol Sci. 2018;43(3):183-192. doi: 10.2131/jts.43.183.

Supplemental Content

Loading ...
Support Center